McGrath KM - Search Results

1

Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies.

Sheridan WP, Begley CG, To LB, Grigg A, Szer J, Maher D, Green MD, Rowlings PA, McGrath KM, Cebon J, et al. Sheridan WP, et al. Among authors: mcgrath km. Bone Marrow Transplant. 1994 Jul;14(1):105-11. Bone Marrow Transplant. 1994. PMID: 7524904 Clinical Trial.

2

Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy.

Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM. Sheridan WP, et al. Among authors: mcgrath km. Lancet. 1992 Mar 14;339(8794):640-4. doi: 10.1016/0140-6736(92)90795-5. Lancet. 1992. PMID: 1371817

3

Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy.

Grigg A, Begley CG, Juttner CA, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM, Sheridan WP. Grigg A, et al. Among authors: mcgrath km. Bone Marrow Transplant. 1993;11 Suppl 2:23-9. Bone Marrow Transplant. 1993. PMID: 8334435

4

Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers.

Grigg AP, Roberts AW, Raunow H, Houghton S, Layton JE, Boyd AW, McGrath KM, Maher D. Grigg AP, et al. Among authors: mcgrath km. Blood. 1995 Dec 15;86(12):4437-45. Blood. 1995. PMID: 8541532 Free article.

5

Marrow proliferation and the appearance of giant neutrophils in response to recombinant human granulocyte colony stimulating factor (rhG-CSF).

Campbell LJ, Maher DW, Tay DL, Boyd AW, Rockman S, McGrath K, Fox RM, Morstyn G. Campbell LJ, et al. Br J Haematol. 1992 Mar;80(3):298-304. doi: 10.1111/j.1365-2141.1992.tb08136.x. Br J Haematol. 1992. PMID: 1374626

6

Early clinical trials with colony-stimulating factors.

Morstyn G, Lieschke GJ, Cebon J, Dührsen U, Villeval JL, Sheridan W, McGrath K, Layton JE. Morstyn G, et al. Cancer Invest. 1989;7(5):443-56. doi: 10.3109/07357908909041375. Cancer Invest. 1989. PMID: 2482790 Review. No abstract available.

7

High-dose chemotherapy with busulphan and cyclophosphamide and bone-marrow transplantation for drug-sensitive malignancies in adults: a preliminary report.

Sheridan WP, Boyd AW, Green MD, Russell DM, Thomas RJ, McGrath KM, Vaughan SL, Scarlett JD, Griffiths JD, Brodie GN, et al. Sheridan WP, et al. Among authors: mcgrath km. Med J Aust. 1989 Oct 2;151(7):379-86. doi: 10.5694/j.1326-5377.1989.tb101219.x. Med J Aust. 1989. PMID: 2677622 Review.

8

T cell lymphoid aggregates in bone marrow in idiopathic hypereosinophilic syndrome.

Metz J, McGrath KM, Savoia HF, Begley CG, Chetty R. Metz J, et al. Among authors: mcgrath km. J Clin Pathol. 1993 Oct;46(10):955-8. doi: 10.1136/jcp.46.10.955. J Clin Pathol. 1993. PMID: 8192747 Free PMC article.

9

Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.

Lieschke GJ, Maher D, O'Connor M, Green M, Sheridan W, Rallings M, Bonnem E, Burgess AW, McGrath K, Fox RM, et al. Lieschke GJ, et al. Cancer Res. 1990 Feb 1;50(3):606-14. Cancer Res. 1990. PMID: 2404573

10

A study of granular lymphoproliferative disorders including a CD3 negative case with a rearrangement of the T-cell receptor locus.

Robb LG, Rockman S, Begley CG, Boyd AW, McGrath K. Robb LG, et al. Leuk Lymphoma. 1994 Mar;13(1-2):143-50. doi: 10.3109/10428199409051665. Leuk Lymphoma. 1994. PMID: 8025515

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240 results

Search Page

Filters